---
Investor Relations

Price: ... AWKN (NEO)

About Awakn

Awakn Life Sciences is a biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder

OBJECTIVE:
To provide breakthrough therapeutics to addiction sufferers

STRATEGY:
To commercialize our R&D pipeline across multiple channels

Awakn corporate information

Download latest Awakn Corporate Presentation and visit Awakn Financials Info on Sedar.

acp

Analyst Coverage

FIRM

Stifel

Maxim Group LLC

ANALYST

Andrew Partheniou

Jason McCarthy

Press releases

Awakn Life Sciences Signs Drug Development Agreement With Catalent For Zydis® Technology (An Orally Disintegrating Tablet) To Conduct Feasibility Studies To Improve Differentiation Of Its MDMA Program

Awakn Life Sciences Signs Drug Development Agreement with Catalent for Zydis® Technology (An Orally Disintegrating Tablet) to Conduct Feasibility Studies to Improve Differentiation of its MDMA Program

TORONTO, CANADA, Sept, 12 2022 – Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (‘Awakn’), a revenue-generating biotechnology company researching, developing, and commercializing therapeutics to treat addiction with a near-term focus on…

Enquiries

Investor relations:

Anthony Tennyson
CEO, Awakn Life Sciences
anthony.tennyson@awaknlifesciences.com

Media enquiries:

Gordo Whittaker,
CMO, Awakn Life Sciences

gordo@awaknlifesciences.com

Sign Up for Newsletter

Back to top Arrow